GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a high-performing
Data & Predictive Sciences will only be successful by working in close collaboration with Research Technologies, Therapy Areas, GSK Tech, AIML, Vaccines, Risk &Compliance, and across lines within the functionitself, and by developing and fostering a high-performing